U.S. Water Utilities Stock News

Credo Technology Group Holding’s PCIe 6.0-capable Toucan retimer has achieved PCI-SIG compliance, confirming it meets industry standards for the latest PCIe 6.0 technology. The company also introduced new connectivity products, including the Blue Heron 224G AI scale-up retimer and additional PCIe 6.0-capable devices aimed at AI and data center workloads. These launches focus on higher bandwidth and reliability for customers building AI clusters and advanced data center infrastructure. Credo...

If you are wondering whether Centuri Holdings' share price still reflects good value, or if the recent excitement has already been priced in, this article will walk you through what the numbers indicate about the stock. The shares last closed at US$31.24, with returns of 0.7% over 7 days, 10.0% over 30 days, 21.0% year to date and 72.1% over the past year. This has naturally raised questions about how the current price compares with underlying value. Recent news flow around Centuri Holdings...

What Proto Labs investors can glean from recent performance Proto Labs (PRLB) has moved sharply over the past year, with the stock returning 57.3% and showing double digit gains over the past month and past 3 months, catching the attention of many investors. Alongside that share price performance, the company reports annual revenue of US$533.1 million and net income of US$21.2 million, with recent annual revenue and net income growth rates of 6.4% and 24.4% respectively. See our latest...

If you are looking at Southern and wondering whether the current share price lines up with its underlying value, you are not alone. Southern's share price recently closed at US$95.18, with returns of 0.2% over 7 days, 8.7% over 30 days, 9.2% year to date, 10.6% over 1 year, 64.5% over 3 years and 98.5% over 5 years shaping how investors are thinking about its potential and risk. Recent coverage of Southern has focused on its position in the US utilities sector and the market's ongoing...

Regions Financial (RF) has drawn fresh attention after major firms including J.P. Morgan and UBS raised their views on the stock, even as recent quarterly results fell short of some market estimates. See our latest analysis for Regions Financial. At a share price of US$28.71, Regions Financial has recently seen a 12.94% 90 day share price return and a 27.80% 1 year total shareholder return, suggesting near term momentum alongside stronger multi year gains as investors reassess earnings...

Genuine Parts plans to separate into two independent, tax free companies by Q1 2027. The split will create a dedicated Global Automotive business and a separate Global Industrial business. The company expects the separation to sharpen business focus and reshape its long term direction. For NYSE:GPC shareholders, this planned breakup comes after a challenging stretch for the stock. Shares are at $116.16, with a 21.1% decline over the past week and a 15.6% decline over the past month. Over 3...

If you are wondering whether Collegium Pharmaceutical at around US$44.85 is good value or looking fully priced, the key is understanding how its current share price stacks up against a few different valuation checks. The stock has had a mixed run recently, with a 2.1% decline over the last 7 days and a 1.4% decline over the last 30 days, even though the 1 year return sits at 53.6% and the 3 year return at 67.4%. Recent attention on Collegium has focused on its position within the US...

In the past few days, law firm Kirby McInerney LLP announced it is investigating Alvotech and certain executives for potential federal securities law violations after the FDA issued a complete response letter citing a failed facility inspection for its AVT05 biologics license application. This combination of regulatory setback and investor scrutiny raises fresh questions about Alvotech’s quality controls, regulatory risk management, and disclosure practices around its biosimilar...

MFA Financial (MFA) is on investor watch after posting annual revenue of US$325.4 million and net income of US$135.7 million, with recent returns mixed over the day, week, month and past 3 months. See our latest analysis for MFA Financial. At a share price of US$9.90, MFA Financial has seen short term share price softness alongside a positive 3 month share price return and a stronger 1 year total shareholder return of 11.27%. This suggests that recent price swings are occurring within a more...

Spectrum Brands Holdings (SPB) has drawn fresh attention after recent trading left the stock with a one-month return of 22% and a gain of 34.1% over the past three months, sharpening interest in its consumer brands portfolio. See our latest analysis for Spectrum Brands Holdings. That recent run sits on top of a 31.43% year to date share price return as the stock trades at US$78.91. The 1 year total shareholder return of 3.46% and 3 year total shareholder return of 33.70% suggest momentum has...

Advanced Energy Industries (NasdaqGS:AEIS) is actively pursuing acquisitions to expand its presence, with recent deals focused on industrial and medical technology. Management has highlighted a busy acquisition pipeline and points to recent integration of new technology as evidence that its inorganic growth push is gaining traction. The company is signaling that further deals in industrial and medical markets are a priority, with the goal of reshaping its portfolio around higher value...

If you are wondering whether OFG Bancorp at around US$41.39 is still good value or already pricing in a lot of optimism, you are asking the right question. The stock has had mixed recent returns, with a 1.2% decline over the last 7 days, an 11.4% gain over 30 days, 0.9% year to date, 2.4% over 1 year, 50.3% over 3 years and 134.3% over 5 years, which can change how investors think about both upside and risk. Recent news around OFG Bancorp has focused on its position as a US regional bank and...

Ategrity Specialty Insurance Company Holdings (ASIC) has drawn fresh attention after a sharp recent move in its share price, with the stock up 6.1% over the past day and 32.7% in the past week. See our latest analysis for Ategrity Specialty Insurance Company Holdings. The recent surge in Ategrity Specialty Insurance Company Holdings’ share price, including a 32.7% 7 day share price return and a 23.97% 90 day share price return, suggests short term momentum is building while year to date...

Berkshire Hathaway disclosed in the fourth quarter that it acquired a little more than five million shares of The New York Times Company, while separately New York Times Advertising and Magnite previously announced an expanded collaboration making Magnite's DV+ the preferred platform for private marketplace deals for the publisher’s mobile in‑app ad supply. The combination of a high‑profile shareholder like Berkshire Hathaway and a deeper in‑app advertising partnership highlights how New...

This article explores whether Mirum Pharmaceuticals, at a share price of US$105.89, may still offer value or whether the current price already reflects a high level of optimism, by examining what the market valuation might be indicating. The stock has delivered returns of 2.7% over the last 7 days, 12.3% over 30 days, 35.6% year to date and 107.8% over 1 year, with a very large 3 year return and a 4.7x gain over 5 years that may have influenced how investors view its risk and reward...

Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase program, giving management more time to execute on the plan. The expanded authorization and longer timeline point to ongoing efforts to return capital to shareholders through repurchases. For investors watching NasdaqGS:PODD, the buyback update comes as the stock trades around $249.38. Recent performance has been mixed, with a 2.7%...

Artisan Partners Asset Management (NYSE:APAM) is expanding its alternatives platform and pursuing new partnerships to support growth. The company is pushing ahead with these initiatives while facing regulatory headwinds and changing client preferences. This shift in focus is intended to broaden its actively managed offering as more capital moves toward passive products. Artisan Partners has built its business around actively managed strategies, and the move into more alternative offerings...

Liberty Latin America is rebuilding its network in Jamaica after Hurricane Melissa while keeping subscriber and B2B growth on track. The company is rolling out 5G standalone mobile services in partnership with Ericsson. Liberty Latin America is working with AWS on cloud and AI capabilities to support its telecom and enterprise offerings. Liberty Latin America, ticker NasdaqGS:LILA, is drawing attention as it works through major operational disruption while still adding postpaid mobile...

Wingstop (NasdaqGS:WING) is facing new global tariffs announced by the Trump administration, which affect international trade and input costs. The company is also under public scrutiny after a former employee publicly alleged issues with labor and management practices. Social media conversations have amplified these accusations, raising questions for customers, employees, and investors. Wingstop, known for its chicken wing restaurants and franchise model, relies on international supply...

GeneDx Holdings (WGS) closed out FY 2025 with Q4 revenue of US$121.0 million and a basic EPS loss of US$0.61, alongside net income excluding extraordinary items of a US$17.7 million loss. Over recent quarters the company has seen revenue move from US$95.6 million in Q4 2024 to US$121.0 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.31 in Q3 2024 to a gain of US$0.38 in Q2 2025 and back to a loss of US$0.61 in the latest period. This sets up a story in which...

If you are wondering whether Incyte at around US$100.85 is priced for its future or leaving some value on the table, this article walks through what the numbers are really saying about the stock. Over the past week Incyte declined 0.3%. Over 30 days it declined 1.1%. Over the last year it returned 36.3%, with 3-year and 5-year returns of 31.6% and 26.6% respectively. These figures can naturally raise questions about where it sits on the risk and reward spectrum today. Recent headlines around...

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 billion in revenue and US$9.45–US$9.65 in diluted EPS, raised its quarterly dividend to US$0.86 per share, and disclosed continued share repurchases under its long-running buyback program. The company also signaled continued expansion by pursuing hospital outreach and independent lab acquisitions, while using its questhealth.com platform...

FuboTV stock after recent performance FuboTV (FUBO) has been under pressure recently, with the share price at US$1.18 and negative returns over the past week, month, past 3 months and year to date drawing fresh attention from investors. See our latest analysis for FuboTV. The recent 1 day share price return of a 4.84% decline adds to a 30 day share price return of a 52.42% decline and a year to date share price return of a 54.44% decline, which points to fading momentum as investors reassess...

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...